Fergany AF, Hafez K, Novick AC. Long-term results of nephron-sparing surgery for localized renal cell carcinoma: 10-year follow-up. J Urol. 1999;163:442–5.
Lee CT, Katz J, Shi W, et al. Surgical managment of renal tumors 4 cm or less in a contemporary cohort. J Urol. 2000;163:730–6.
Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182:1271–9.
Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol.2015;67:913–24.
Breau RH, Crispen PL, Jimenez RE, et al. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol. 2010;183:903–8.
Daugherty M, Bratslavsky G. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (< 4 cm): an analysis of the SEER database. Semin Urol Oncol. 2014;32:549–54.
Kim SP, Campbell SC, Gill I, et al. Collaborative review of risk benefit trade-offs between partial and radical nephrectomy in the management of anatomically complex renal masses. Eur Urol. 2017;72:64–75.
Ghani KR, Sukumar S, Sammon JD, et al. Practice patterns and outcomes of open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: results from the nationwide inpatient sample. J Urol. 2014;191:907–13.
Bjurlin MA, Walter D, Taksler GB, et al. National trends in the utilization of partial nephrectomy before and after the establishment of AUA guidelines for the management of renal masses. Urology. 2013;82:1283–90.
Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology. 2006;67:254–9.
HCUP Nationwide Inpatient Sample (NIS). Healthcare cost and utilization project (HCUP), Rockville, MD. Agency for Health-Care Research and Quality, 2012. Retrieved April 1, 2019, at www.hcup-us.ahrq.gov/nisoverview.jsp.
Groeben C, Koch R, Baunacke M, et al. Urinary diversion after radical cystectomy for bladder cancer: comparing trends in the US and Germany from 2006 to 2014. Ann Surg Oncol. 2018;25:3502–9.
Hager B, Kraywinkel K, Keck B, et al. Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: a comparison of treatment trends in the United States and Germany from 2004 to 2011. Radiother Oncol. 2015;115:90–5.
Gettman MT, Blute ML, Chow GK, et al. Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with daVinci robotic system. Urology. 2004;64:914–8.
Aboumarzouk OM, Tietze S, Eyraud R, et al. Robotic versus laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol. 2012;62:1023–33.
Sun M, Abdollah F, Shariat SF, et al. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series. Eur J Surg Oncol. 2012;38:80–7.
Groeben C, Koch R, Baunacke M, Wirth MP, Huber J. Robots drive the German radical prostatectomy market: a total population analysis from 2006 to 2013. Prostate Cancer Prostatic Dis. 2016;23:1–5.
Patel HD, Mullins JK, Pierorazio PM, et al. Trends in renal surgery: robotic technology is associated with increased use of partial nephrectomy. J Urol. 2013;189:1229–35.
Sivarajan G, Taksler GB, Walter D, et al. The effect of the diffusion of the surgical robot on the hospital-level utilization of partial nephrectomy. Med Care. 2015;53:71–8.
Ljungberg B, Hanbury DC, Kuczyk MA, et al. Renal cell carcinoma guideline. Eur Urol. 2007;51:1502–10.
Ridic G, Gleason S, Ridic O. Comparisons of health care systems in the United States, Germany, and Canada. Mater Sociomed. 2012;24:112–20.
Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA. 2018;319:1024–39.
Uzzo RG, Wei JT, Hafez K, Kay R, Novick AC. Comparison of direct hospital costs and length of stay for radical nephrectomy versus nephron-sparing surgery in the managment of localized renal cell carcinoma. Urology. 1999;54:994–8.
Tanagho YS, Figenshau RS, Sandhu GS, Bhayani SB. Is there a financial disincentive to perform partial nephrectomy? J Urol. 2012;187:1995–9.
Dickman SL, Himmelstein DU, Woolhandler S. Inequality and the health-care system in the USA. Lancet. 2017;389:1431–41.
Diaz A, Schoenbrunner A, Pawlik TM. Trends in the geospatial distribution of inpatient adult surgical services across the United States. Ann Surg. 2019. https://doi.org/10.1097/SLA.0000000000003366.
Weight CJ, Crispen PL, Breau RH, et al. Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. BJU Int. 2012;111:731–8.
Woldrich J, Palazzi K, Stroup SP, et al. Trends in the surgical management of localized renal masses: thermal ablation, partial, and radical nephrectomy in the USA, 1998–2008. BJU Int. 2013;111:1261–8.
Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198:520–9.
Vigneswaran HT, Lec P, Brito J, et al. Partial nephrectomy for small renal masses: do teaching and nonteaching institutions adhere to guidelines equally? J Endourol. 2016;30:714–21.